Alveron produces drugs such as cyclodextrins, pro-coagualant cyclodextrins with a unique coagulation platform technology.
Alveron Pharma has raised $5.3M in total funding. The most recent round was Seed. The last funding was announced in December 2024.
Alveron Pharma's investors include Thuja Capital, Broadview Ventures, OostNL, Netherlands Enterprise Agency, Sanquin.
Alveron Pharma is headquartered in Nijmegen, The Netherlands.
Alveron produces drugs such as cyclodextrins, pro-coagualant cyclodextrins with a unique coagulation platform technology.
Alveron Pharma is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Alveron Pharma — Funding & Investors." VCBacked, December 6, 2024, https://www.vcbacked.co/company/alveron-pharma. Accessed October 28, 2026.
VCBacked. (2024). Alveron Pharma — Funding & Investors. Retrieved October 28, 2026, from https://www.vcbacked.co/company/alveron-pharma
{{cite web |title=Alveron Pharma — Funding & Investors |url=https://www.vcbacked.co/company/alveron-pharma |website=VCBacked |access-date=October 28, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated